Re: eGFR and Cognition?
|
3
|
Resverlogix Corp.
|
Nov 23, 2019 04:49PM
|
Re: Breakthrough Therapy Designation Application
|
3
|
Resverlogix Corp.
|
Dec 06, 2019 10:48AM
|
Re: Financial Future
|
3
|
Resverlogix Corp.
|
May 13, 2019 12:09PM
|
Re: Clinical trials query results
|
3
|
Zenith Epigenetics
|
Apr 08, 2021 11:41AM
|
Re: One more Exempt Distribution - 2021-04-26
|
3
|
Resverlogix Corp.
|
Apr 28, 2021 10:22AM
|
Re: ZHCLF
|
3
|
Zenith Epigenetics
|
Feb 01, 2024 10:24AM
|
Re: Got this when I inquired (today) about participating in the PP,....
|
3
|
Resverlogix Corp.
|
Jun 03, 2019 06:11PM
|
Re: The Revelation
|
3
|
Resverlogix Corp.
|
Nov 10, 2019 12:46PM
|
Re: Positive data on cognition already 'baked in'?
|
3
|
Resverlogix Corp.
|
Dec 03, 2019 12:10PM
|
Re: Financial Future
|
3
|
Resverlogix Corp.
|
May 13, 2019 12:34PM
|
Re: The chart set up looks awesome imo....
|
3
|
Resverlogix Corp.
|
Dec 03, 2019 12:24PM
|
Interim Financial .... Interim MD&A .... Reporting
|
3
|
Zenith Epigenetics
|
Apr 05, 2024 05:49PM
|
Re: Don's latest presentation
|
3
|
Resverlogix Corp.
|
Sep 22, 2020 09:26AM
|
Re: Buy-Out
|
3
|
Resverlogix Corp.
|
Nov 21, 2019 04:46PM
|
Exempt Distributions - Dec 9, 2022 & Jan 13, 2023
|
3
|
Zenith Epigenetics
|
Jan 18, 2023 04:54PM
|
Re: IR
|
3
|
Resverlogix Corp.
|
Jan 14, 2023 10:08AM
|
Re: BTD
|
3
|
Resverlogix Corp.
|
Apr 25, 2022 07:36AM
|
Re: OTC Short interest up 0.88%/around 7k shrs to 767,637 as of the end of Feb
|
3
|
Resverlogix Corp.
|
Mar 11, 2022 04:38PM
|
Re: realisticly how long do they even have to try & close this "purposed offering" 4-6 weeks max?
|
3
|
Resverlogix Corp.
|
May 15, 2019 10:11AM
|
Re: Win or lose....one thing we know for sure
|
3
|
Resverlogix Corp.
|
Aug 31, 2019 01:27PM
|